Weekly Update on Ebola Virus Disease (EVD) Preparedness for South Sudan Update #14 (03 December 2018)
GenXpert laboratory results for the suspected EVD case in Yambio were negative for Ebola Zaire; follow-up polymerase chain reaction (PCR) testing was negative for all Ebola species, Marburg,
Rift Valley Fever, Crimean Congo Hemorrhagic Fever, and Sosuga viruses. Further testing of the sample at Uganda Virus Research Institute (UVRI) using Taqman Array Card (TAC) platform and YF-specific PCR assay confirmed that the sample was PCR positive for Yellow Fever Virus.
Another suspected EVD case was reported in Yambio. The GenXpert analysis of the sample was negative for Ebola Zaire while the PCR results were negative for all Ebola species, Marburg, Rift Valley Fever, Crimean Congo Hemorrhagic Fever, and Sosuga viruses. Further testing showed the sample was positive for Streptococcus pneumoniae and Plasmodium falciparum by TAC PCR.
All technical working groups have reviewed the prioritization spreadsheet, NTF constitution recommendations, and Terms of Reference.
Infection prevention and Control and Case Management, Safe and Dignified Burial and Border Health and Port of Entry Technical working groups have finalized the SoPs. We are following-up on Risk Communication and Community Engagement, Access, Safety and Security, Logistics,
Surveillance and Laboratory technical working groups on their finalized SoPs.
Entry screening of travelers into South Sudan continues in all the 18 designated sites with support from Ministry of Health (MoH), World Health Organization (WHO), International Organization for Migration (IOM), Save the Children International, (SCI), World Vision International South Sudan (WVISS) and Collegio Universtario Aspirante Medici Missionari (CAUMM). The porous border crossing points are major threats to the screening activities at the border posts; about 637,880 people have been screened at the 18 border crossing points.
An EVD alert was reported in Renk. A national RRT was dispatched to investigate the case; samples were collected and delivered to the National Public Health Laboratory, Juba, and (NPHL). GenXpert testing at NPHL and PCR at UVRI are awaited.